IGC BIO
Boston, US · Founded 2014 · Delaware corporation
Founders & leadership
Board
JW
Jeremy WertheimerBoard director
TE
Tamar ErdfarbBoard director
JJ
Joseph JacobsonBoard director
OK
Oded KadoshBoard director
Reported raises · per SEC filings
Form D private placements$4.2M disclosed across 2 rounds · 2016–2017
▶$1.6MraisedJul 2018 · 1 investors · BiotechnologyRule 506(b)
▶$1.6MraisedJul 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeremy WertheimerDirector
- Joseph JacobsonDirector
- Oded KadoshDirector
- Offering amount
- $1.6M
- Amount sold
- $1.6M
- First sale
- Oct 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$2.5MraisedOct 2016 · 1 investors · BiotechnologyRule 506(b)
▶$2.5MraisedOct 2016 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Tamar ErdfarbDirector
- Joseph JacobsonDirector
- Jeremy WertheimerDirector
- Oded KadoshDirector
- Offering amount
- $2.5M
- Amount sold
- $2.5M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Frequently asked questions
- How much funding has IGC BIO raised?
- IGC BIO has disclosed $4.2M raised across 2 rounds.
- Where is IGC BIO headquartered?
- IGC BIO is headquartered in Boston, US.